Concepedia

Beata Holkova

BH

22

Publications

876

Citations

16

H-Index

2001

Active since

Affiliations

Virginia Commonwealth University(Current)

Institute for Molecular Medicine

Emory University

The University of Texas MD Anderson Cancer Center

City Of Hope National Medical Center

Beata Holkova is an author at Virginia Commonwealth University specializing in medicine, radiation oncology, and health sciences.

ORCID

Top concepts

Publications per year

2001–2022

22

Publications

22

Immunomodulatory Drug CC-5013 or CC-4047 and Rituximab Enhance Antitumor Activity in a Severe Combined Immunodeficient Mouse Lymphoma Model

Francisco J. Hernandez‐Ilizaliturri, Nishitha Reddy, Beata Holkova et al. · Clinical Cancer Research · 2005 · 172 citations

Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older

Andres Forero‐Torres, Beata Holkova, Jerome H. Goldschmidt et al. · Blood · 2015 · 137 citations · Full text

Effect of Highly Active Antiretroviral Therapy on Survival in Patients With AIDS-Associated Pulmonary Kaposi’s Sarcoma Treated With Chemotherapy

Beata Holkova, Kenichi Takeshita, Debbie M. Cheng et al. · Journal of Clinical Oncology · 2001 · 97 citations

Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory B-Cell Neoplasms

Beata Holkova, Edward Brent Perkins, Viswanathan Ramakrishnan et al. · Clinical Cancer Research · 2011 · 48 citations · Full text

A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma

Beata Holkova, Adriana Zingone, Maciej Kmieciak et al. · Clinical Cancer Research · 2015 · 48 citations · Full text

Rows per page

1–5 of 22